Skip to main content
Top
Published in: Clinical & Experimental Metastasis 6/2010

Open Access 01-08-2010 | Review

Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases

Authors: Ewa Bien, Lucyna Maciejka-Kapuscinska, Maciej Niedzwiecki, Joanna Stefanowicz, Anna Szolkiewicz, Malgorzata Krawczyk, Jadwiga Maldyk, Ewa Izycka-Swieszewska, Beata Tokarska, Anna Balcerska

Published in: Clinical & Experimental Metastasis | Issue 6/2010

Login to get access

Abstract

The paper presents diagnostic and therapeutic difficulties in two adolescents with widespread rhabdomyosarcoma (RMS) presenting with severe haemorrhages resulting from disseminated intravascular coagulation (DIC) and with laboratory features of acute tumour lysis syndrome (ATLS). Other published cases of childhood RMS with DIC at admission have been listed and reviewed. It has been concluded that the clinical picture of a widespread RMS in children may resemble acute hematologic malignancy and pose a big diagnostic problem. That is why the presence of small blue round cells morphologically similar to lymphoblasts and/or myeloblasts in bone marrow (BM), lacking hematopoietic makers, should prompt the pathologist to consider possible diagnosis of RMS. Inclusion of desmin, MyoD1 and myogenin Myf4 to the immunohistochemical panel is obligatory in such cases. When the representative histopathological tumour specimens are difficult to obtain, the flow cytometric immunophenotyping of BM metastases could help the standard morphological/immunohistological diagnostic procedures and advance the diagnosis. Recently, the flow cytometric CD45− CD56+ immunophenotype together with Myf4 transcript has been assigned to RMS cells infiltrating BM. In children with disseminated RMS complicated with DIC rapid polychemotherapy aimed at diminishing the malignancy-triggered procoagulant activity should be initiated. However, in cases with concomitant ATLS the initial doses of chemotherapy should be reduced and the metabolic disorders and renal function monitored. The prognosis in children with RMS metastatic to BM with signs of DIC or ATLS at admission depends on the response to chemotherapy, however generally it is highly disappointing.
Literature
1.
go back to reference Levi M, de Jonge E, van der Poll T (2004) New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 36:41–49CrossRefPubMed Levi M, de Jonge E, van der Poll T (2004) New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 36:41–49CrossRefPubMed
2.
go back to reference Avvisati G, Lo Coco F, Mandelli F (2001) Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors. Semin Hematol 38:4–12CrossRefPubMed Avvisati G, Lo Coco F, Mandelli F (2001) Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors. Semin Hematol 38:4–12CrossRefPubMed
3.
go back to reference Sallah S, Wan JY, Nguyen NP et al (2001) Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost 86:828–833PubMed Sallah S, Wan JY, Nguyen NP et al (2001) Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost 86:828–833PubMed
4.
go back to reference Duran I, Tannock IF (2006) Disseminated intravascular coagulation as the presenting sign of metastatic prostate cancer. J Gen Intern Med 21:C6–C8CrossRefPubMed Duran I, Tannock IF (2006) Disseminated intravascular coagulation as the presenting sign of metastatic prostate cancer. J Gen Intern Med 21:C6–C8CrossRefPubMed
5.
go back to reference Oh WK (2002) Hematologic complications of prostate cancer. Prostate cancer, principles and practice. Lippincott Williams and Wilkins, Philadelphia Oh WK (2002) Hematologic complications of prostate cancer. Prostate cancer, principles and practice. Lippincott Williams and Wilkins, Philadelphia
6.
go back to reference De la Fouchardiere C, Flechon A, Droz JP (2003) Coagulopathy in prostate cancer. Neth J Med 61:347–354 De la Fouchardiere C, Flechon A, Droz JP (2003) Coagulopathy in prostate cancer. Neth J Med 61:347–354
7.
go back to reference Okajima K, Sakamoto Y, Uchiba M (2000) Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases. Am J Hematol 65:215–222CrossRefPubMed Okajima K, Sakamoto Y, Uchiba M (2000) Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases. Am J Hematol 65:215–222CrossRefPubMed
8.
go back to reference Levi M, de Jonge E, van der Poll T et al (2001) Advances in the under standing of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies. Semin Thromb Hemost 27:569–575CrossRefPubMed Levi M, de Jonge E, van der Poll T et al (2001) Advances in the under standing of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies. Semin Thromb Hemost 27:569–575CrossRefPubMed
9.
go back to reference Ishibashi M, Ito N, Fujita M et al (1994) Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms. Cancer 73:191–195CrossRefPubMed Ishibashi M, Ito N, Fujita M et al (1994) Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms. Cancer 73:191–195CrossRefPubMed
11.
go back to reference Stouthard J, Levi M, Hack CE et al (1996) Interleukin-6 stimulates coagulation but not fibrinolysis in humans. Thromb Haemost 76:738–742PubMed Stouthard J, Levi M, Hack CE et al (1996) Interleukin-6 stimulates coagulation but not fibrinolysis in humans. Thromb Haemost 76:738–742PubMed
12.
go back to reference Taylor FB Jr, Toh CH, Hoots WK et al (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330PubMed Taylor FB Jr, Toh CH, Hoots WK et al (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330PubMed
13.
go back to reference Levi M (2004) Systemic microangiopathies in the cancer patient. In: Lugassy G (ed) Thrombosis and cancer. Taylor and Francis, London Levi M (2004) Systemic microangiopathies in the cancer patient. In: Lugassy G (ed) Thrombosis and cancer. Taylor and Francis, London
14.
go back to reference Navarro M, Ruiz I, Martín G et al (2006) Patient with disseminated intravascular coagulation as the first manifestation of adenocarcinoma of the prostate. Risks of prostatic biopsy. Prostate Cancer Prostatic Dis 9:190–191CrossRefPubMed Navarro M, Ruiz I, Martín G et al (2006) Patient with disseminated intravascular coagulation as the first manifestation of adenocarcinoma of the prostate. Risks of prostatic biopsy. Prostate Cancer Prostatic Dis 9:190–191CrossRefPubMed
15.
go back to reference Uchiumi H, Matsushima T, Yamane A et al (2007) Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Int J Hematol 86:137–142CrossRefPubMed Uchiumi H, Matsushima T, Yamane A et al (2007) Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation. Int J Hematol 86:137–142CrossRefPubMed
16.
17.
go back to reference Khan J, Broadbent V (1993) Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma. Pediatr Hematol Oncol 10:151–155CrossRefPubMed Khan J, Broadbent V (1993) Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma. Pediatr Hematol Oncol 10:151–155CrossRefPubMed
18.
go back to reference Sills RH, Stockman JA III, Miller ML et al (1978) Consumptive coagulopathy. A complication of therapy of solid tumors in childhood. Am J Dis Child 132:870–872PubMed Sills RH, Stockman JA III, Miller ML et al (1978) Consumptive coagulopathy. A complication of therapy of solid tumors in childhood. Am J Dis Child 132:870–872PubMed
19.
go back to reference Goldschmidt B, Koos R (1980) Low intensity intravascular coagulation in rhabdomyosarcoma. Orv Hetil 121:905–907PubMed Goldschmidt B, Koos R (1980) Low intensity intravascular coagulation in rhabdomyosarcoma. Orv Hetil 121:905–907PubMed
20.
go back to reference Butler WM, Sciala SJ, Taylor HG (1982) Alveolar rhabdomyosarcoma associated with disseminated intravascular coagulation and a unique factor VIII antigen. Arch Intern Med 142:1379–1380CrossRefPubMed Butler WM, Sciala SJ, Taylor HG (1982) Alveolar rhabdomyosarcoma associated with disseminated intravascular coagulation and a unique factor VIII antigen. Arch Intern Med 142:1379–1380CrossRefPubMed
21.
go back to reference Furui T, Ichihara K, Ikeda A et al (1983) Subdural hematoma associated with disseminated intravascular coagulation in patients with advanced cancer. J Neurosurg 58:398–401CrossRefPubMed Furui T, Ichihara K, Ikeda A et al (1983) Subdural hematoma associated with disseminated intravascular coagulation in patients with advanced cancer. J Neurosurg 58:398–401CrossRefPubMed
22.
go back to reference Rhymann FB, Newton WA, Ragab AH (1984) Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. Cancer 53:368–373CrossRef Rhymann FB, Newton WA, Ragab AH (1984) Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. Cancer 53:368–373CrossRef
23.
go back to reference Stéphan JL, Massoubre C, Bertheas MF et al (1996) Fulminant disseminated intravascular coagulation revealing an advanced stage IV poorly differentiated rhabdomyosarcoma. Eur J Pediatr 155:622–623CrossRefPubMed Stéphan JL, Massoubre C, Bertheas MF et al (1996) Fulminant disseminated intravascular coagulation revealing an advanced stage IV poorly differentiated rhabdomyosarcoma. Eur J Pediatr 155:622–623CrossRefPubMed
24.
go back to reference Sakurai JO, Yamada K, Iwasaki M et al (1999) A case of rhabdomyosarcoma of the retroperitoneum in adolescence. Nippon Gekakei Rengo Gakkaishi 24:653–656 Sakurai JO, Yamada K, Iwasaki M et al (1999) A case of rhabdomyosarcoma of the retroperitoneum in adolescence. Nippon Gekakei Rengo Gakkaishi 24:653–656
25.
go back to reference Yamaguchi K, Koga Y, Suminoe A et al (2007) Alveolar rhabdomyosarcoma of unknown origin mimicking acute leukemia at the initial presentation. Rinsho Ketsueki 48:315–320PubMed Yamaguchi K, Koga Y, Suminoe A et al (2007) Alveolar rhabdomyosarcoma of unknown origin mimicking acute leukemia at the initial presentation. Rinsho Ketsueki 48:315–320PubMed
26.
27.
28.
go back to reference Muzaffar AR, Friedrich JB, Lu KK et al (2006) Infantile fibrosarcoma of the hand associated with coagulopathy. Plast Reconstr Surg 117:81e–86eCrossRefPubMed Muzaffar AR, Friedrich JB, Lu KK et al (2006) Infantile fibrosarcoma of the hand associated with coagulopathy. Plast Reconstr Surg 117:81e–86eCrossRefPubMed
29.
go back to reference Manger DC (1971) Letterer-Siwe’s disease: a case complicated by disseminated intravascular coagulation and responding to heparin therapy. Pediatrics 47:435–438 Manger DC (1971) Letterer-Siwe’s disease: a case complicated by disseminated intravascular coagulation and responding to heparin therapy. Pediatrics 47:435–438
30.
go back to reference Rhymann FB, Newton WA, Ragab AH (1984) Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. Cancer 53:368–373CrossRef Rhymann FB, Newton WA, Ragab AH (1984) Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. Cancer 53:368–373CrossRef
31.
go back to reference Fiegl M, Weltermann A, Stindl R et al (1999) Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literature. Ann Hematol 78:335–338CrossRefPubMed Fiegl M, Weltermann A, Stindl R et al (1999) Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literature. Ann Hematol 78:335–338CrossRefPubMed
32.
go back to reference Stéphan JL, Massoubre C, Bertheas MF et al (1996) Fulminant disseminated intravascular coagulation revealing an advanced stage IV poorly differentiated rhabdomyosarcoma. Eur J Pediatr 155:622–623CrossRefPubMed Stéphan JL, Massoubre C, Bertheas MF et al (1996) Fulminant disseminated intravascular coagulation revealing an advanced stage IV poorly differentiated rhabdomyosarcoma. Eur J Pediatr 155:622–623CrossRefPubMed
33.
go back to reference Tobar A, Avigad S, Zoldan M et al (2000) Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma. Diagn Mol Pathol 9:9–13CrossRefPubMed Tobar A, Avigad S, Zoldan M et al (2000) Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma. Diagn Mol Pathol 9:9–13CrossRefPubMed
34.
go back to reference Sandberg AA, Stone JF, Czarnecki L et al (2001) Hematologic masquerade of rhabdomyosarcoma. Am J Hematol 68:51–57CrossRefPubMed Sandberg AA, Stone JF, Czarnecki L et al (2001) Hematologic masquerade of rhabdomyosarcoma. Am J Hematol 68:51–57CrossRefPubMed
35.
go back to reference Reinecke P, Gerharz CD, Thiele KP et al (2000) Temporary remission of an alveolar rhabdomyosarcoma diagnosed and treated as acute leukemia. Leuk Lymphoma 36:405–409CrossRefPubMed Reinecke P, Gerharz CD, Thiele KP et al (2000) Temporary remission of an alveolar rhabdomyosarcoma diagnosed and treated as acute leukemia. Leuk Lymphoma 36:405–409CrossRefPubMed
36.
go back to reference Srinivas U, Pillai L, Kar R et al (2007) A case of rhabdomyosarcoma masquerading as acute leukemia at presentation: a case report. Indian J Pathol Microbiol 50:917–919PubMed Srinivas U, Pillai L, Kar R et al (2007) A case of rhabdomyosarcoma masquerading as acute leukemia at presentation: a case report. Indian J Pathol Microbiol 50:917–919PubMed
37.
go back to reference Bozzi F, Collini P, Aiello A et al (2008) Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma. Anticancer Res 28:1565–1569PubMed Bozzi F, Collini P, Aiello A et al (2008) Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma. Anticancer Res 28:1565–1569PubMed
38.
go back to reference Kussick SJ, Wood BW, Li Y (2001) Using antibodies to CD56 and CD45 to identify nonhematopoietic small blue round cell tumors by flow cytometry [abstract]. Am J Clin Pathol 116:279 Kussick SJ, Wood BW, Li Y (2001) Using antibodies to CD56 and CD45 to identify nonhematopoietic small blue round cell tumors by flow cytometry [abstract]. Am J Clin Pathol 116:279
39.
40.
go back to reference Weltermann A, Mitterbauer GJ, Mitterbauer M et al (1998) Disseminated intravascular coagulation with excessive fibrinolysis in a patient with metastatic endometrial carcinoma—influence of various treatments on the coagulopathy (a case report). Wien Klin Wochenschr 110:53–57PubMed Weltermann A, Mitterbauer GJ, Mitterbauer M et al (1998) Disseminated intravascular coagulation with excessive fibrinolysis in a patient with metastatic endometrial carcinoma—influence of various treatments on the coagulopathy (a case report). Wien Klin Wochenschr 110:53–57PubMed
41.
go back to reference Cerone JR, Kanwar VS, Sills RH (2006) Consumption coagulopathy. Article last updated: 6 Jan 2009 Cerone JR, Kanwar VS, Sills RH (2006) Consumption coagulopathy. Article last updated: 6 Jan 2009
43.
go back to reference Bell WR, Starksen NF, Tong S et al (1985) Trousseau’s syndrome. Devastating coagulopathy in the absence of heparin. Am J Med 79:423–430CrossRefPubMed Bell WR, Starksen NF, Tong S et al (1985) Trousseau’s syndrome. Devastating coagulopathy in the absence of heparin. Am J Med 79:423–430CrossRefPubMed
44.
go back to reference Pernerstorfer T, Hollenstein U, Hansen J et al (1999) Heparin blunts endotoxin-induced coagulation activation. Circulation 100:2485–2490PubMed Pernerstorfer T, Hollenstein U, Hansen J et al (1999) Heparin blunts endotoxin-induced coagulation activation. Circulation 100:2485–2490PubMed
Metadata
Title
Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases
Authors
Ewa Bien
Lucyna Maciejka-Kapuscinska
Maciej Niedzwiecki
Joanna Stefanowicz
Anna Szolkiewicz
Malgorzata Krawczyk
Jadwiga Maldyk
Ewa Izycka-Swieszewska
Beata Tokarska
Anna Balcerska
Publication date
01-08-2010
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 6/2010
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-010-9335-y

Other articles of this Issue 6/2010

Clinical & Experimental Metastasis 6/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine